Matches in Wikidata for { <http://www.wikidata.org/entity/Q91436145> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q91436145 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q91436145 description "scientific article published on 01 March 2020" @default.
- Q91436145 description "wetenschappelijk artikel" @default.
- Q91436145 description "наукова стаття, опублікована 1 березня 2020" @default.
- Q91436145 name "Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient" @default.
- Q91436145 name "Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient" @default.
- Q91436145 type Item @default.
- Q91436145 label "Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient" @default.
- Q91436145 label "Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient" @default.
- Q91436145 prefLabel "Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient" @default.
- Q91436145 prefLabel "Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient" @default.
- Q91436145 P1433 Q91436145-4FC0D44A-2202-49B6-90DD-72C2A9725CB9 @default.
- Q91436145 P1476 Q91436145-F0194BD3-2DA5-44C1-A54B-B22BC49816A9 @default.
- Q91436145 P2093 Q91436145-07581268-7768-4CE2-9480-9E142BABA61E @default.
- Q91436145 P2093 Q91436145-1FE9B09B-E875-44CF-8189-29C1D044B1D7 @default.
- Q91436145 P2093 Q91436145-6BC29DB8-F8B8-46B1-9A34-FB22F1A23371 @default.
- Q91436145 P2093 Q91436145-6E58F030-61D8-4F8E-B496-65CC60B56AFB @default.
- Q91436145 P2093 Q91436145-7EDF91C1-DD29-42DD-B98F-FACE0DF988EA @default.
- Q91436145 P2093 Q91436145-81A25F3E-3839-4AF6-957E-7E47E406624D @default.
- Q91436145 P2093 Q91436145-88ED5E53-D763-4A82-8BE8-A1670E6953DA @default.
- Q91436145 P2093 Q91436145-911139A7-FF97-4F17-96C9-B388308B3AE5 @default.
- Q91436145 P2093 Q91436145-AFBFD365-E81A-4E2E-B037-34C9E56CA9AB @default.
- Q91436145 P2093 Q91436145-E18E6A99-38FE-4B34-AC68-29C56A384695 @default.
- Q91436145 P2093 Q91436145-E1AAD41A-7F0D-4FF9-BFFF-0A1DF1891336 @default.
- Q91436145 P304 Q91436145-008B31B3-CEA8-4B8B-B718-D6EBCF10BBF6 @default.
- Q91436145 P31 Q91436145-02EB38A5-8BD2-41AD-BF47-F2B73827A878 @default.
- Q91436145 P356 Q91436145-88C042D9-B80E-4057-9811-47942D90D1A5 @default.
- Q91436145 P433 Q91436145-7B51AE76-A2CF-4808-A38E-C27975626B5A @default.
- Q91436145 P478 Q91436145-ED3E33D2-C209-426C-AEE1-31D116CE9C9D @default.
- Q91436145 P50 Q91436145-E7FB7A56-6034-44CF-8130-5F7124A92154 @default.
- Q91436145 P577 Q91436145-3AD7E700-E311-408A-9BB6-2F2DDBA9BF48 @default.
- Q91436145 P698 Q91436145-B88E5959-B354-433C-985A-853424414F98 @default.
- Q91436145 P921 Q91436145-BE54A4C6-83BC-439E-9DDE-27593C846EDE @default.
- Q91436145 P356 HJH.0000000000002279 @default.
- Q91436145 P698 31764586 @default.
- Q91436145 P1433 Q6295318 @default.
- Q91436145 P1476 "Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient" @default.
- Q91436145 P2093 "Bojan Jelaković" @default.
- Q91436145 P2093 "Christina Antza" @default.
- Q91436145 P2093 "Dragan Micic" @default.
- Q91436145 P2093 "Giuseppe Mancia" @default.
- Q91436145 P2093 "Jens Jordan" @default.
- Q91436145 P2093 "Kostas Tsioufis" @default.
- Q91436145 P2093 "Markus P Schlaich" @default.
- Q91436145 P2093 "Peter M Nilsson" @default.
- Q91436145 P2093 "Reinhold Kreutz" @default.
- Q91436145 P2093 "Stella Stabouli" @default.
- Q91436145 P2093 "Vasilios Kotsis" @default.
- Q91436145 P304 "377-386" @default.
- Q91436145 P31 Q13442814 @default.
- Q91436145 P356 "10.1097/HJH.0000000000002279" @default.
- Q91436145 P433 "3" @default.
- Q91436145 P478 "38" @default.
- Q91436145 P50 Q61303944 @default.
- Q91436145 P577 "2020-03-01T00:00:00Z" @default.
- Q91436145 P698 "31764586" @default.
- Q91436145 P921 Q3025883 @default.